Cargando…

SKA3 overexpression predicts poor outcomes in skin cutaneous melanoma patients

BACKGROUND: Spindle and Kinetochore Associated Complex Subunit 3 (SKA3) is a part of the SKA complex, which plays a key role in cell mitosis. Studies have shown that SKA3 was associated with cancer progression. However, its role in skin cutaneous melanoma (SKCM) remains unclear. Here, we investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Hao, Zhou, Yongting, Wang, Jie, Wu, Hao, Cui, Chenyang, Xiao, Zhibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571110/
https://www.ncbi.nlm.nih.gov/pubmed/34737118
http://dx.doi.org/10.1016/j.tranon.2021.101253
_version_ 1784594947364618240
author Pang, Hao
Zhou, Yongting
Wang, Jie
Wu, Hao
Cui, Chenyang
Xiao, Zhibo
author_facet Pang, Hao
Zhou, Yongting
Wang, Jie
Wu, Hao
Cui, Chenyang
Xiao, Zhibo
author_sort Pang, Hao
collection PubMed
description BACKGROUND: Spindle and Kinetochore Associated Complex Subunit 3 (SKA3) is a part of the SKA complex, which plays a key role in cell mitosis. Studies have shown that SKA3 was associated with cancer progression. However, its role in skin cutaneous melanoma (SKCM) remains unclear. Here, we investigated the expression level and prognostic value of SKA3 in SKCM. METHODS: Based on public databases, univariate and multivariate Cox regression analyses were used to investigate the different expression of SKA3 between SKCM and normal tissues. Then, the relationship between SKA3 expression level and prognosis was assessed. PPI network and functional enrichment analysis were performed. ESTIMATE and CIBERSORT were expected to evaluate the SKA3 expression and immune status. CCK8, wound healing, transwell assays and tumor xenograft trial were performed to detect the SKA3 function in cell viability, migration and invasion of the cell lines. RESULTS: The SKA3 was highly expressed in SKCM tissues. SKA3 overexpression was associated with poor survival and immune status. SKA3 knockdown inhibited cell viability, migration and invasion of SKCM cells. CONCLUSION: SKA3 is involved in the progression of SKCM and may serve as a new prognostic biomarker and therapeutic target.
format Online
Article
Text
id pubmed-8571110
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Neoplasia Press
record_format MEDLINE/PubMed
spelling pubmed-85711102021-11-10 SKA3 overexpression predicts poor outcomes in skin cutaneous melanoma patients Pang, Hao Zhou, Yongting Wang, Jie Wu, Hao Cui, Chenyang Xiao, Zhibo Transl Oncol Original Research BACKGROUND: Spindle and Kinetochore Associated Complex Subunit 3 (SKA3) is a part of the SKA complex, which plays a key role in cell mitosis. Studies have shown that SKA3 was associated with cancer progression. However, its role in skin cutaneous melanoma (SKCM) remains unclear. Here, we investigated the expression level and prognostic value of SKA3 in SKCM. METHODS: Based on public databases, univariate and multivariate Cox regression analyses were used to investigate the different expression of SKA3 between SKCM and normal tissues. Then, the relationship between SKA3 expression level and prognosis was assessed. PPI network and functional enrichment analysis were performed. ESTIMATE and CIBERSORT were expected to evaluate the SKA3 expression and immune status. CCK8, wound healing, transwell assays and tumor xenograft trial were performed to detect the SKA3 function in cell viability, migration and invasion of the cell lines. RESULTS: The SKA3 was highly expressed in SKCM tissues. SKA3 overexpression was associated with poor survival and immune status. SKA3 knockdown inhibited cell viability, migration and invasion of SKCM cells. CONCLUSION: SKA3 is involved in the progression of SKCM and may serve as a new prognostic biomarker and therapeutic target. Neoplasia Press 2021-10-29 /pmc/articles/PMC8571110/ /pubmed/34737118 http://dx.doi.org/10.1016/j.tranon.2021.101253 Text en © 2021 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Pang, Hao
Zhou, Yongting
Wang, Jie
Wu, Hao
Cui, Chenyang
Xiao, Zhibo
SKA3 overexpression predicts poor outcomes in skin cutaneous melanoma patients
title SKA3 overexpression predicts poor outcomes in skin cutaneous melanoma patients
title_full SKA3 overexpression predicts poor outcomes in skin cutaneous melanoma patients
title_fullStr SKA3 overexpression predicts poor outcomes in skin cutaneous melanoma patients
title_full_unstemmed SKA3 overexpression predicts poor outcomes in skin cutaneous melanoma patients
title_short SKA3 overexpression predicts poor outcomes in skin cutaneous melanoma patients
title_sort ska3 overexpression predicts poor outcomes in skin cutaneous melanoma patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571110/
https://www.ncbi.nlm.nih.gov/pubmed/34737118
http://dx.doi.org/10.1016/j.tranon.2021.101253
work_keys_str_mv AT panghao ska3overexpressionpredictspooroutcomesinskincutaneousmelanomapatients
AT zhouyongting ska3overexpressionpredictspooroutcomesinskincutaneousmelanomapatients
AT wangjie ska3overexpressionpredictspooroutcomesinskincutaneousmelanomapatients
AT wuhao ska3overexpressionpredictspooroutcomesinskincutaneousmelanomapatients
AT cuichenyang ska3overexpressionpredictspooroutcomesinskincutaneousmelanomapatients
AT xiaozhibo ska3overexpressionpredictspooroutcomesinskincutaneousmelanomapatients